Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Fisetin, found in fruits and vegetables, may help treat various health conditions like inflammation, diabetes, heart issues, cancer, and hair loss.

Stimulating sensory neurons can increase IGF-I production, which may help treat various diseases and improve tissue health.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Myo-inositol with magnesium effectively reduces acne and hirsutism in PCOS patients without side effects.

Silibinin may help promote hair growth and treat hair loss.

Ruxolitinib treatment may cause eyelash growth.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

MIM is crucial for hair follicle formation and regeneration by controlling cilia formation and hedgehog signaling through its interaction with Cortactin and Src.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Compound Baqia Danshen Liniment may effectively treat vitiligo by improving skin and hair pigmentation and reducing inflammation.

Compounds from Ziziphus spina-christi roots show strong antibacterial and antioxidant potential.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

p120-catenin helps control skin inflammation by regulating cadherin levels.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Linagliptin may cause hair loss and skin blisters.

Human insulin via microinfusion may effectively improve atrophic acne scars.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Nilotinib can cause keratosis pilaris, a skin condition.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.